Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1999-11-24
pubmed:abstractText
The extracellular matrix glycoprotein tenascin-C is widely expressed during development and repair, making it surprising that few abnormalities have been found in transgenic mice lacking this molecule. We have therefore re-examined the transgenic mice described by Saga et al. [Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T. & Aizawa, S. (1992) Genes Dev., 6 1821-1831] in which tenascin-C was knocked-out by homologous recombination, focusing on two aspects of the nervous system likely to reveal any abnormalities that might follow the loss of tenascin-C. First, we have determined the pattern of myelin and distribution of oligodendrocyte precursor cells in those areas, such as the optic nerve and retina where local concentrations of tenascin-C have been proposed to act as barriers to oligodendrocyte precursor migration and so prevent inappropriate myelination. Secondly, we have examined the behaviour of the mice in a number of well-characterized tests, e.g. beam-walking, passive avoidance and the Morris water maze. We find no abnormalities of myelination or oligodendrocyte precursor distribution in adult mice, showing that local concentrations of tenascin-C are not the sole mechanism responsible for the pattern of myelination in these regions of CNS. However, we do find a number of behavioural abnormalities in these mice and show that hyperlocomotion and deficits in coordination during beam walking can be ascribed to tenascin-C deficiency. The effects on coordination are, however, not seen on a 129 genetic background. Taken together, these results significantly extend the phenotype associated with tenascin-C deficiency but argue against a role in myelination.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0953-816X
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3082-92
pubmed:dateRevised
2009-9-29
pubmed:meshHeading
pubmed-meshheading:10510172-Animals, pubmed-meshheading:10510172-Avoidance Learning, pubmed-meshheading:10510172-Behavior, Animal, pubmed-meshheading:10510172-Exploratory Behavior, pubmed-meshheading:10510172-Female, pubmed-meshheading:10510172-Fluorescent Antibody Technique, Direct, pubmed-meshheading:10510172-Heterozygote, pubmed-meshheading:10510172-Immunohistochemistry, pubmed-meshheading:10510172-In Situ Hybridization, pubmed-meshheading:10510172-Male, pubmed-meshheading:10510172-Maze Learning, pubmed-meshheading:10510172-Mice, pubmed-meshheading:10510172-Mice, Inbred C57BL, pubmed-meshheading:10510172-Mice, Transgenic, pubmed-meshheading:10510172-Motor Activity, pubmed-meshheading:10510172-Myelin Basic Proteins, pubmed-meshheading:10510172-Myelin Sheath, pubmed-meshheading:10510172-Postural Balance, pubmed-meshheading:10510172-Reflex, pubmed-meshheading:10510172-Species Specificity, pubmed-meshheading:10510172-Startle Reaction, pubmed-meshheading:10510172-Tenascin
pubmed:year
1999
pubmed:articleTitle
Myelination and behaviour of tenascin-C null transgenic mice.
pubmed:affiliation
Wellcome/CRC Institute of Developmental Biology and Cancer, Cambridge, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't